To provide a solution for this, Zarkogianni et al. designed and evaluated a personalized insulin infusion advisory system (IIAS) that uses insulin pumps and continuous glucose monitors to provide real-time insulin rate estimations for patients with Type 1 diabetes [139]. This evidence concerns the gene INS and type 1 diabetes mellitus.